Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,085 across all filing types
Latest filing 2018-05-20 Notice of Dividend Amou…
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
2017年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled '2017 年年度权益分派实施公告' which translates to '2017 Annual Equity Distribution Implementation Announcement'. It details the dividend distribution plan approved at the 2017 Annual General Meeting, including dividend amounts, record dates, and payment methods. The document references the shareholder meeting resolutions and the dividend payment schedule. It does not contain financial statements or comprehensive financial performance data, but rather announces the implementation of the dividend distribution. The document length is short (1796 characters) and it serves as an announcement of dividend amount and payment details. Therefore, it fits the category of 'Notice of Dividend Amount' (DIV).
2018-05-20 Chinese
2017年年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2017 Annual General Meeting (AGM) of a company. It details the convening, attendance, voting procedures, and results of the AGM, confirming the legality and validity of the meeting and its resolutions. The document does not contain financial statements or detailed financial performance data, nor is it a report or announcement of financial results. Instead, it is a legal opinion related to the AGM proceedings and voting outcomes. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of the AGM.
2018-05-10 Chinese
2017年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a 2017 Annual General Meeting (AGM) resolution announcement for the company 西藏易明西雅医药科技股份有限公司. It details the convening of the AGM, voting procedures, attendance, and the voting results on various agenda items including approval of the 2017 annual reports, financial statements, profit distribution plan, and other corporate governance matters. The document does not contain the full annual report or financial statements themselves but reports on the resolutions passed at the AGM. The length is about 4701 characters, which is relatively short and consistent with an announcement rather than a full report. The content is focused on the voting results and meeting details, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2018-05-10 Chinese
关于全资子公司完成工商注册登记并取得营业执照的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a company about its wholly-owned subsidiary completing business registration and obtaining a business license. It includes details such as company name, registration code, legal representative, registered capital, and business scope. There is no financial data, no mention of financial results, no regulatory certifications, or meeting materials. The document is short (881 characters) and serves as an official announcement of a corporate event (subsidiary registration). This fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2018-05-02 Chinese
2018年第一季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2018 First Quarter Report" of 西藏易明西雅医药科技股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data such as revenue, net profit, cash flow, and changes in financial indicators for the first quarter of 2018. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year confirms it is an Interim / Quarterly Report. The document length (7816 characters) and content show it is the actual report, not just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2018
2018-04-24 Chinese
2018年第一季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2018 First Quarter Report" of 西藏易明西雅医药科技股份有限公司, indicating it is a quarterly financial report. It contains detailed financial statements including consolidated and parent company balance sheets, profit and loss statements, cash flow data, and management commentary on financial performance and changes. The presence of actual financial data and analysis for the first quarter of 2018 confirms it is a comprehensive interim/quarterly report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2018
2018-04-24 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.